Recurrent stroke in symptomatic carotid stenosis awaiting revascularization: A pooled analysis
Elias Johansson1, Elisa Cuadrado-Godia2, Derek Hayden1
1From the Department of Public Health and Clinical Medicine, Umeå Stroke Centre (E.J., J.B., P.W.), and Department of Pharmacology and Clinical Neuroscience (E.J.), Umeå University, Sweden; Department of Neurology (E.C.-G., A.O., J.R.), Neurovascular Research Group, IMIM-Hospital del Mar (Institut Hospital del Mar d'Investigacions Mèdiques), Universitat Autònoma de Barcelona/DCEXS-Universitat Pompeu Fabra, Spain; and Neurovascular Unit for Translational and Therapeutics Research (D.H., P.J.K.), Mater University Hospital/Dublin Academic Medical Centre, Dublin, Ireland.
Patients with symptomatic carotid stenosis face a high risk of recurrent stroke before revascularization. Urgent intervention may be necessary to prevent further ischemic events.
Area of Science:
- Neurology
- Vascular Surgery
- Epidemiology
Background:
- Symptomatic carotid stenosis poses a significant risk of ischemic stroke.
- Current guidelines recommend revascularization within 14 days for eligible patients.
Purpose of the Study:
- To quantify the risk and identify predictors of ipsilateral ischemic stroke in patients with symptomatic carotid stenosis awaiting revascularization.
- To pool individual patient data from recent prospective studies with high rates of modern stroke prevention medications.
Main Methods:
- Pooled individual patient data from 2 prospective hospital-based registries and 1 prospective population-based study.
- Included patients with symptomatic 50%-99% carotid stenosis eligible for carotid revascularization.
- Followed patients for early recurrent ipsilateral stroke or retinal artery occlusion (RAO).
Main Results:
- Of 377 eligible patients, ipsilateral recurrent ischemic stroke/RAO risk was 11.5% at 14 days and 18.8% at 90 days.
- Older age (HR per 10-year increase 1.5) was associated with increased recurrence risk.
- A trend for higher risk was observed for cerebral versus ocular symptoms (adjusted HR 2.7).
Conclusions:
- High risk of recurrent ipsilateral ischemic events exists within 14 days, the current recommended timeframe for carotid endarterectomy (CEA).
- Randomized trials are needed to evaluate the benefits and safety of urgent versus subacute carotid revascularization within 14 days of symptom onset.
More Related Videos
09:11Performing Permanent Distal Middle Cerebral with Common Carotid Artery Occlusion in Aged Rats to Study Cortical Ischemia with Sustained Disability
Published on: February 23, 2016
04:30A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis
Published on: May 14, 2013
